A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia-Reference-Cited by-同舟云学术

A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia

Published:2004-11 Issue:11 Volume:26 Page:1758-1773
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Bays Harold E.,Ose Leiv,Fraser Neil,Tribble Diane L.,Quinto Katherine,Reyes Robert,Johnson-Levonas Amy O.,Sapre Aditi,Donahue Steven R.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference48 articles.

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);JAMA,2001

2. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT);Stamler;JAMA,1986

3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S);Lancet,1994

4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS;Downs;JAMA,1998

5. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ezetimibe on markers of inflammation in patients treated with statins: a systematic review;Inflammopharmacology;2023-06-01

2. Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid-Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus;Contemporary Diabetes;2023

3. Preformulation Studies of Ezetimibe-Simvastatin Solid Dispersions in the Development of Fixed-Dose Combinations;Pharmaceutics;2022-04-22

4. Cholesterol metabolism related genes in osteoarthritis;Bone;2021-11

5. Carotid Artery Temperature Reduction with Statin Therapy in Patients with Familial Hyperlipidemia Syndromes;Journal of Clinical Medicine;2021-10-27